Amisulpride augmentation of clozapine: an open non‐randomized study in patients with schizophrenia partially responsive to clozapine

Abstract

Co-administration of amisulpride, in a group of patients partially or non-responsive to clozapine, may lead to a substantial improvement in positive and negative symptoms, without worsening the side effect burden.